International Journal of Polymer Science

International Journal of Polymer Science / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 736898 | 8 pages |

Electrical Signal Guided Ibuprofen Release from Electrodeposited Chitosan Hydrogel

Academic Editor: Qijin Zhang
Received05 Mar 2014
Accepted02 Aug 2014
Published19 Aug 2014


Electrical signal guided drug release from conductive surface provides a simple and straightforward way for advanced drug delivery. In this study, we investigated the ibuprofen release from electrodeposited chitosan hydrogel by applying electrical signals. Specifically, chitosan hydrogel was electrodeposited on titanium plate and used as a matrix for ibuprofen load and release. The release of ibuprofen from the chitosan hydrogel on titanium plate was pH sensitive. By applying a positive or negative electrical potential, the release rate of ibuprofen from the electrodeposited chitosan can be facilely controlled. Thus, coupling chitosan electrodeposition and electrical signal control spurs new possibilities for biopolymeric coating and drug elution on conductive implants.

1. Introduction

External stimuli triggered drug release alters the traditional way of drug delivery and causes substantial attention and interests [1]. Generally, on demand release happens when external stimuli such as light [2], magnetic field [3, 4], heat [5], or pH [6] were applied to the release matrix. Electrical signal is simple to use and has the advantage of easy combination to remote control, and, thus, it has been used in embedded drug delivery chips [7, 8]. Recently, using electrical signal to control the drug release from biopolymers prompts even more opportunities for biomedicine and advanced therapy.

Chitosan is an aminopolysaccharide derived from chitin, which can be found in the shells of crabs and shrimps [9]. Due to its intriguing biocompatibility, biodegradability, and nontoxicity, chitosan has been studied extensively as drug carrier in the field of pharmaceutics and biomedicine [1016]. Previously, we showed that chitosan could be electrodeposited on electrodes as a hydrogel by enlisting its pH responsive and film forming properties [17, 18]. The electrodeposition process includes the neutralization of chitosan chains by locally generated pH gradient and the sol-gel transition of chitosan in situ [19, 20]. Strong noncovalent bonds such as hydrogen bonds and hydrophobic interactions are responsible for the generation of chitosan hydrogel. Various biocomponents such as proteins [2123], cells [24, 25], antibiotics [26], and nanocomponents [27] can be entrapped in the porous network of the deposited chitosan hydrogel. The above work demonstrates the capability of electrodeposited chitosan as drug reservoir and the potential for controlled drug release.

In this work, we demonstrate the controlled drug release from electrodeposited chitosan by applying electrical signals. The manipulation of electrical signals causes the on-site generation of chitosan hydrogel and sequentially controlled drug release from the hydrogel. It couples the advantage of chitosan hydrogel as preferable drug carrier and the straightforwardness of electrical signals. The procedure was illustrated in Scheme 1. Firstly, chitosan was electrodeposited on titanium plate by biasing a negative potential to generate a hydrogel. Then the titanium plate with electrodeposited chitosan hydrogel was immersed in ibuprofen solution (pH 10) for drug load. The profile of ibuprofen release from the chitosan hydrogel was adjusted by applying electrical potentials. Electrochemical reactions on the titanium plate caused by the negative or positive potential changed the local pH of the chitosan hydrogel, thus varying the ibuprofen release rate. We believe that this easy and benign drug load and release procedure should have potential applications in smart drug release from conductive implant or lab on a chip.


2. Experimental

2.1. Materials

Chitosan with medium molecular weight and a degree of deacetylation (DD) of 85% was purchased from Sigma. Ibuprofen was purchased from Shanghai Yuan-Ji Chemical Reagent Co., Ltd. Titanium plates with a thickness of 100 μm were purchased from Baoji Titanium Company, Shanxi. Other chemicals were of analytical grade and were purchased from Sinopharm Chemical Reagent Co. without further purification.

2.2. Electrodeposition of Chitosan Hydrogel on Titanium Plates

Electrodeposition of chitosan hydrogel on titanium plates was carried out by using a conventional two-electrode system as described previously [26]. The working electrode was a titanium plate with a size of 1.5 × 3.5 cm2 and the reference electrode was a platinum wire. All the electrodes were sonicated consecutively before use in the bath of acetone, ethanol, and water for 5 min each. Chitosan solution (1%, wt) was prepared by mixing chitosan flakes with distilled water followed by adjusting the pH to 3 by adding HCl solution. Undissolved part was removed by a 0.45 μm syringe filter unit. The pH of chitosan solution was adjusted to ~5 by using 1 M NaOH. Before deposition, H2O2 and NaCl were added to the chitosan solution to a final concentration of 20 mM for H2O2 and 43 mM for NaCl [28]. The electrodes were partially dipped into the chitosan solution and the distance between the electrodes and the immersion depth were both kept at 2 cm. Then the electrodes were connected to a power supply (CHI 624D electrochemistry workstation, Shanghai, China) and applied a constant voltage of −3.0 V for 30 min. After that, the titanium plate with electrodeposited chitosan hydrogel was removed from the system and rinsed briefly with distilled water for further usage.

2.3. Drug Load on Titanium Plate

Various concentrations of ibuprofen solution were prepared by dissolving ibuprofen flakes in glycine/sodium hydroxide buffer and the pH was adjusted to 10 by adding 1 M NaOH. The titanium plate with deposited chitosan hydrogel was immersed in ibuprofen solution for 1 h. Then the titanium plate with chitosan hydrogel was removed from the ibuprofen solution and rinsed carefully with distilled water. The amount of ibuprofen loaded in chitosan hydrogel was measured by UV-Vis spectroscopy at 264 nm and determined as the percentage of ibuprofen to the total weight of drug loaded chitosan gel.

2.4. Characterization

The morphology of the chitosan hydrogel with loaded ibuprofen was examined by scanning electron microscopy (SEM). The dried chitosan-ibuprofen coating on the titanium plate was sputtered with gold and the morphology of the film was observed at an acceleration voltage of 5 kV. The infrared spectrum of the chitosan-ibuprofen coating was collected by Fourier transform infrared spectroscopy (FT-IR, Nicolet Corporation 5700) using KBr pellets method. The X-ray diffraction (XRD) patterns were obtained on a SHIMADZU XRD-6000 diffractometer (Cu Kα radiation) with a multipurpose sample holder for nondestructive analysis.

2.5. Electrical and pH Controlled Drug Release

The pH responsive ibuprofen release from electrodeposited chitosan hydrogel was monitored by immersing the titanium plate with deposited chitosan in 20 mL buffer solutions with different pH values (pH 4, 7, and 10). At predetermined intervals, the released ibuprofen was measured by UV absorbance at 264 nm. Each assay was performed in triplicate and reported as the average with standard deviation.

The electrical signal controlled drug release was carried out by immersing titanium plates with chitosan-ibuprofen composite hydrogel in NaCl solution (0.9%, w/v). The release of ibuprofen was controlled by applying a voltage to the titanium plate (voltage typically varied between −3 V and +3 V) with a platinum wire working as counter electrode. The elution of ibuprofen responding to applied voltage and time was measured by UV absorbance at 264 nm.

3. Results and Discussion

We first deposited chitosan hydrogel on a titanium plate under a constant current of 0.5 mA for 30 min and then immersed the hydrogel in ibuprofen solution (1%, wt) for 1 h. Figure 1 shows the photographs of the composite chitosan-ibuprofen hydrogel. The hydrogel is transparent and uniform with a smooth surface (Figures 1(a) and 1(b)). The size of the hydrogel is 1.5 × 2.0 cm, which is corresponding to the area dipped in chitosan solution during electrodeposition process. The thickness is estimated to be 1 mm. When the hydrogel was air-dried, irregular white textures appeared on the titanium plate (Figure 1(c)). The texture was further observed by a photomicroscope. Crystals of ibuprofen with needle shape are well dispersed in chitosan film (Figure 1(d), the insert of Figure 1(d) shows one crystal with 500 μm length and 30 μm width). The results in Figure 1 preliminarily suggest that ibuprofen can be loaded in the deposited chitosan hydrogel.

The chitosan-ibuprofen composite film was further characterized by SEM. Figure 2 shows the SEM images of the surface of chitosan-ibuprofen composite film. Chitosan film without ibuprofen displays a relatively smooth surface with micropores of ~0.6 μm (Figure 2(a)). When the chitosan hydrogel was immersed in 0.2% of ibuprofen solution for 1 h, the surface of the chitosan film became rough. The fibril structure on the surface was attributed to the crystallization of ibuprofen in chitosan membrane (Figure 2(b)). Figures 3(b) and 4(b) exhibit the surface morphology of chitosan-ibuprofen in 0.6% and 1.0% of ibuprofen solution, respectively. Obvious crystal structure can be observed with the increased concentration of ibuprofen. It is interesting to note that ibuprofen crystal shows well-oriented layer structure, as revealed by inset images in Figures 2(c) and 2(d). It has been reported that the morphology of the recrystallized ibuprofen depends on the crystallization solvents and additives. The crystal forms of ibuprofen were found as {100}, {002}, and {011} [29]. The carboxyl groups of ibuprofen project out from the face (100) and can form hydrogen bonding with hydroxyl groups on chitosan, thus reducing the growth rate on this face. The growth on (011) face leads to large platelet structure as observed in SEM.

The chitosan-ibuprofen composite film was peeled off from the titanium plate and analyzed by FT-IR (Figure 3). The spectra were compared to that of pure ibuprofen and chitosan. Ibuprofen exhibits characteristic peaks at 2955 cm−1 and 1719 cm−1, which can be attributed to O–H stretching and carbonyl stretching, respectively. Due to the presence of benzene ring, the strong peak at 779 cm−1 represents the aromatic C–H stretching [30]. The spectrum of chitosan shows absorption bands at 1650 cm−1 and 1553 cm−1, corresponding to carbonyl stretching and amide II absorption, respectively. The FT-IR spectra of chitosan-ibuprofen composite films show the peaks at 779 cm−1 and 2955 cm−1, providing evidence that ibuprofen exists in the composite film. However, there is no peak showed at 1719 cm−1, suggesting that the carbonyl group might be ionized in the membrane.

The X-ray diffraction patterns of chitosan-ibuprofen composite films are provided in Figure 4. The sharp and intense peaks at 12.1°, 16.6°, 17.7°, and 22.2° suggest that ibuprofen is highly crystallized [31]. The wide crystalline peak at 19.8° in chitosan indicates its partial crystallization feature. In the chitosan-ibuprofen composite films, the crystalline peaks of ibuprofen remain and the intensity is enhanced with the increased amount of loaded ibuprofen, suggesting that the ibuprofen stays in crystalline state in the composite film.

To determine the amount of ibuprofen incorporated in chitosan-ibuprofen films, the ibuprofen in the film was extracted by immersing the film in ethanol for 1 h and its concentration was determined by UV-Vis spectroscopy at 264 nm. As shown in Figure 5, the amount of loaded ibuprofen in chitosan hydrogel increases proportionally to the concentration of ibuprofen. Due to the limited solubility of ibuprofen in water phase, the highest concentration of ibuprofen tested in this study was 1%. In this case, the load percentage of ibuprofen reaches 39.04%. This relatively large carrying amount of ibuprofen indicates remarkable drug load capacity of the electrodeposited chitosan hydrogel.

Next we investigated the influence of pH in release medium on the release profile of ibuprofen. Figure 6 shows the profiles of ibuprofen release under various pH values. It is obvious that the release rate in neutral buffer (pH = 7) was noticeably higher than that in acidic solution (pH = 4) but lower than that in base condition (pH = 10). As ibuprofen is a weak acidic drug, the elution of ibuprofen from chitosan is pH dependent. It has a small solubility in acid and can be easily dissolved at high pH. At pH 4, less than 30% of ibuprofen was released in 24 h, while this value increased with the increase of pH in the release medium. At pH 10, ibuprofen was released to 64% in the first 2 h and approximately to 78% in 12 h. The release profiles of ibuprofen indicate the important role of pH in the release of ibuprofen.

Inspired by the pH mediated ibuprofen release, we tested the possibility of ibuprofen release controlled by using electrical signals. In general, the electrochemical reaction induced by applied potential will result in pH gradient near the electrodes. The electrolysis of water induces a local pH increase at the cathode and a local pH decrease at the anode [32, 33]. The titanium plate with ibuprofen loaded chitosan hydrogel was immersed in 0.9% NaCl and external potential was applied (−3 V, 0 V, +3 V). As shown in Figure 7(a), ibuprofen release from the composite hydrogel depends on the voltage applied for drug release. In the first 10 min, 14% of ibuprofen was released from the titanium plate at +3.0 V, while only 0.8% of ibuprofen was released at −3.0 V. This discrepancy can be explained by the different electrochemically generated local pH values adjacent to titanium plate that modifies the elution behavior of ibuprofen from the chitosan hydrogel. By biasing a negative potential (−3.0 V), the consumption of H+ will increase the pH near the titanium plate, thus shrinking the chitosan hydrogel on its surface. On the other hand, the increased pH also facilitates the dissolution of ibuprofen. The amount of ibuprofen release reached a plateau of 66% at −3.0 V, while the total cumulative release was merely 31% at +3.0 V. Figure 7(b) and Figure 7(c) show the SEM images of chitosan hydrogels by applying −3.0 V and +3.0 V, respectively. No large ibuprofen crystals can be seen, indicating the release of ibuprofen. The hydrogel under +3.0 V reveals a more porous morphology than the hydrogel under −3.0 V, which is in agreement with the different pH environments at different voltages. The results in Figure 7 demonstrate that the flexible ibuprofen release profile can be mediated by applying varying potentials.

4. Conclusions

In this report, we electrodeposited chitosan on titanium plate and ibuprofen was loaded efficiently by a simple immersion method. The elution of ibuprofen is pH dependent. As a proof of concept study, the release profile of ibuprofen can be controlled by biasing negative or positive potentials, which is dramatically different from the situation of no voltage applied. The results provided in this work suggest new possibilities for building functional biopolymeric coat on conductive implant and controlling drug release by external electrical signals.

Conflict of Interests

The authors declare no competing financial interest.

Authors’ Contribution

Youyu Liu and Kun Yan contributed equally to this work.


This work was financially supported by the National Natural Science Foundation of China (Grant nos. 51373124 and 21007049), Program for New Century Excellent Talents in University (NECT-10-0618), and Natural Science Foundation of Hubei Province (2011CDB268). The authors thank the Large-Scale Instrument and Equipment Sharing Foundation of Wuhan University for the support.


  1. Y. Qiu and K. Park, “Environment-sensitive hydrogels for drug delivery,” Advanced Drug Delivery Reviews, vol. 64, pp. 49–60, 2012. View at: Publisher Site | Google Scholar
  2. J. Lu, E. Choi, F. Tamanoi, and J. I. Zink, “Light-activated nanoimpeller-controlled drug release in cancer cells,” Small, vol. 4, no. 4, pp. 421–426, 2008. View at: Publisher Site | Google Scholar
  3. T. Liu, S. Hu, K. Liu, D. Liu, and S. Chen, “Preparation and characterization of smart magnetic hydrogels and its use for drug release,” Journal of Magnetism and Magnetic Materials, vol. 304, no. 1, pp. e397–e399, 2006. View at: Publisher Site | Google Scholar
  4. N. S. Satarkar and J. Z. Hilt, “Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release,” Journal of Controlled Release, vol. 130, no. 3, pp. 246–251, 2008. View at: Publisher Site | Google Scholar
  5. X.-Z. Zhang, D.-Q. Wu, and C.-C. Chu, “Synthesis, characterization and controlled drug release of thermosensitive IPN-PNIPAAm hydrogels,” Biomaterials, vol. 25, no. 17, pp. 3793–3805, 2004. View at: Publisher Site | Google Scholar
  6. S. Chen, Y. Wu, F. Mi, Y. Lin, L. Yu, and H. Sung, “A novel pH-sensitive hydrogel composed of N,O-carboxymethyl chitosan and alginate cross-linked by genipin for protein drug delivery,” Journal of Controlled Release, vol. 96, no. 2, pp. 285–300, 2004. View at: Publisher Site | Google Scholar
  7. R. Farra, N. F. Sheppard Jr., L. McCabe et al., “First-in-human testing of a wirelessly controlled drug delivery microchip,” Science Translational Medicine, vol. 4, no. 122, 2012. View at: Publisher Site | Google Scholar
  8. J. H. Prescott, S. Lipka, S. Baldwin et al., “Chronic, programmed polypeptide delivery from an implanted, multireservoir microchip device,” Nature Biotechnology, vol. 24, no. 4, pp. 437–438, 2006. View at: Publisher Site | Google Scholar
  9. M. Rinaudo, “Chitin and chitosan: properties and applications,” Progress in Polymer Science, vol. 31, no. 7, pp. 603–632, 2006. View at: Publisher Site | Google Scholar
  10. H. Onishi, Y. Saito, M. Sasatsu, and Y. MacHida, “Kinetic analysis of in vitro and in vivo release of prednisolone from the conjugate of glycol-chitosan and succinyl-prednisolone,” International Journal of Pharmaceutics, vol. 410, no. 1-2, pp. 17–22, 2011. View at: Publisher Site | Google Scholar
  11. A. di Martino, M. Sittinger, and M. V. Risbud, “Chitosan: a versatile biopolymer for orthopaedic tissue-engineering,” Biomaterials, vol. 26, no. 30, pp. 5983–5990, 2005. View at: Publisher Site | Google Scholar
  12. Q. Wang, N. Zhang, X. Hu, J. Yang, and Y. Du, “Chitosan/polyethylene glycol blend fibers and their properties for drug controlled release,” Journal of Biomedical Materials Research A, vol. 85, no. 4, pp. 881–887, 2008. View at: Publisher Site | Google Scholar
  13. Q. Wang, N. Zhang, X. Hu, J. Yang, and Y. Du, “Chitosan/starch fibers and their properties for drug controlled release,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 66, no. 3, pp. 398–404, 2007. View at: Publisher Site | Google Scholar
  14. T. Oosegi, H. Onishi, and Y. Machida, “Gastrointestinal distribution and absorption behavior of Eudragit-coated chitosan-prednisolone conjugate microspheres in rats with TNBS-induced colitis,” International Journal of Pharmaceutics, vol. 348, no. 1-2, pp. 80–88, 2008. View at: Publisher Site | Google Scholar
  15. D. Narayanan, A. Anitha, R. Jayakumar, and K. P. Chennazhi, “PTH 1-34 loaded thiolated chitosan nanoparticles for osteoporosis: oral bioavailability and anabolic effect on primary osteoblast cells,” Journal of Biomedical Nanotechnology, vol. 10, pp. 166–178, 2014. View at: Google Scholar
  16. A. Anitha, S. Uthaman, S. V. Nair, R. Jayakumar, and V. Lakshmanan, “Enhanced delivery system of flutamide loaded chitosan-dextran sulphate nanoparticles for prostate cancer,” Journal of Biomedical Nanotechnology, vol. 9, no. 3, pp. 335–347, 2013. View at: Publisher Site | Google Scholar
  17. X.-W. Shi, L. Qiu, Z. Nie, L. Xiao, G. F. Payne, and Y. Du, “Protein addressing on patterned microchip by coupling chitosan electrodeposition and “electro-click” chemistry,” Biofabrication, vol. 5, no. 4, Article ID 041001, 2013. View at: Publisher Site | Google Scholar
  18. X. Wei, G. F. Payne, X. Shi, and Y. Du, “Electrodeposition of a biopolymeric hydrogel in track-etched micropores,” Soft Matter, vol. 9, no. 7, pp. 2131–2135, 2013. View at: Publisher Site | Google Scholar
  19. Y. Liu, B. Zhang, K. M. Gray et al., “Electrodeposition of a weak polyelectrolyte hydrogel: remarkable effects of salt on kinetics, structure and properties,” Soft Matter, vol. 9, no. 9, pp. 2703–2710, 2013. View at: Publisher Site | Google Scholar
  20. Y. Cheng, X. Luo, J. Betz et al., “In situ quantitative visualization and characterization of chitosan electrodeposition with paired sidewall electrodes,” Soft Matter, vol. 6, no. 14, pp. 3177–3183, 2010. View at: Publisher Site | Google Scholar
  21. Y. Wang, Y. Liu, Y. Cheng et al., “Coupling electrodeposition with layer-by-layer assembly to address proteins within microfluidic channels,” Advanced Materials, vol. 23, no. 48, pp. 5817–5821, 2011. View at: Publisher Site | Google Scholar
  22. K. M. Gray, B. D. Liba, Y. Wang et al., “Electrodeposition of a biopolymeric hydrogel: potential for one-step protein electroaddressing,” Biomacromolecules, vol. 13, no. 4, pp. 1181–1189, 2012. View at: Publisher Site | Google Scholar
  23. X.-W. Shi, X. Yang, K. J. Gaskell et al., “Reagentless protein assembly triggered by localized electrical signals,” Advanced Materials, vol. 21, no. 9, pp. 984–988, 2009. View at: Publisher Site | Google Scholar
  24. W. Ghach, M. Etienne, P. Billard, F. P. A. Jorand, and A. Walcarius, “Electrochemically assisted bacteria encapsulation in thin hybrid sol-gel films,” Journal of Materials Chemistry B, vol. 1, no. 7, pp. 1052–1059, 2013. View at: Publisher Site | Google Scholar
  25. C. Hao, L. Ding, X. Zhang, and H. Ju, “Biocompatible conductive architecture of carbon nanofiber-doped chitosan prepared with controllable electrodeposition for cytosensing,” Analytical Chemistry, vol. 79, no. 12, pp. 4442–4447, 2007. View at: Publisher Site | Google Scholar
  26. X. Shi, H. Wu, Y. Li, X. Wei, and Y. Du, “Electrical signals guided entrapment and controlled release of antibiotics on titanium surface,” Journal of Biomedical Materials Research A, vol. 101, no. 5, pp. 1373–1378, 2013. View at: Publisher Site | Google Scholar
  27. G. F. Payne and S. R. Raghavan, “Chitosan: a soft interconnect for hierarchical assembly of nano-scale components,” Soft Matter, vol. 3, no. 5, pp. 521–527, 2007. View at: Publisher Site | Google Scholar
  28. K. Yan, F. Ding, W. E. Bentley, H. Deng, Y. Du, G. F. Payne et al., “Coding for hydrogel organization through signal guided self-assembly,” Soft Matter, vol. 10, pp. 465–469, 2014. View at: Google Scholar
  29. H. Cano, N. Gabas, and J. P. Canselier, “Experimental study on the ibuprofen crystal growth morphology in solution,” Journal of Crystal Growth, vol. 224, no. 3-4, pp. 335–341, 2001. View at: Publisher Site | Google Scholar
  30. I. A. Sogias, A. C. Williams, and V. V. Khutoryanskiy, “Chitosan-based mucoadhesive tablets for oral delivery of ibuprofen,” International Journal of Pharmaceutics, vol. 436, no. 1-2, pp. 602–610, 2012. View at: Publisher Site | Google Scholar
  31. S. Mallick, S. Pattnaik, K. Swain et al., “Formation of physically stable amorphous phase of ibuprofen by solid state milling with kaolin,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 68, no. 2, pp. 346–351, 2008. View at: Publisher Site | Google Scholar
  32. S. Murdan, “Electro-responsive drug delivery from hydrogels,” Journal of Controlled Release, vol. 92, no. 1-2, pp. 1–17, 2003. View at: Publisher Site | Google Scholar
  33. S. H. Yuk, S. H. Cho, and H. B. Lee, “Electric current-sensitive drug delivery systems using sodium alginate/polyacrylic acid composites,” Pharmaceutical Research, vol. 9, no. 7, pp. 955–957, 1992. View at: Publisher Site | Google Scholar

Copyright © 2014 Youyu Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1391 Views | 678 Downloads | 5 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.